menu search

Cassava sciences slumps after leaked report claims 'egregious misconduct' over alzheimer's drug

Cassava sciences Inc has denied data manipulation after a probe into conduct over its Alzheimer's drug ...

October 13, 2023, 10:06 am

Hyvelocity selected by u.s. department of energy to develop gulf coast hydrogen hub

HyVelocity will rapidly scale clean hydrogen supply and demand and deliver community benefits along the...

October 13, 2023, 10:05 am

Henry schein: economic value matches market-implied expectations, reiterate hold

Henry schein's stock price continues to decline, reflecting lower expectations for the company. The mar...

October 13, 2023, 9:55 am

Bellway and barratt kick off housebuilders reporting season as mortgage squeeze remains in focus

The housing market and specifically housebuilders Bellway PLC (LSE:BWY) and Barratt Developments PLC (LSE:BDEV) will be under the micro...

October 13, 2023, 9:46 am

1 growth stock down 96% to buy right now

fuboTV has all the sports that consumers seek without the channels they don't want. Continued and projected sub...

October 13, 2023, 9:45 am

Across u.s., chinese bitcoin mines draw national security scrutiny

Records show other cryptocurrency facilities have ties to the Chinese state. A Bitcoin mine in Cheyenne, Wyo.Credit…Video by Chet Strange Supported ...

October 13, 2023, 9:44 am

Market analysis: the probability of oil prices rising to $100 is increasing

This week, Saudi energy minister Prince Abdulaziz bin Salman visited Moscow to di...

October 13, 2023, 9:29 am

Charles schwab expected to report tough 3q as interest income comes under pressure

Charles schwab (NYSE:scHW) is expected to post lower rev...

October 13, 2023, 9:11 am

Alpine immune sciences to present initial clinical data on povetacicept in autoimmune glomerulonephritis in a late breaker poster session at american society of nephrology kidney week 2023

SEATTLE--(BUSINESS WIRE)--Alpine Immune sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunot...

October 13, 2023, 9:05 am

Viasat (vsat) offers business update, affirms fy24 & fy25 view

In fiscal 2025, Viasat (VSAT) expects to record synergies to the tune of $80 million in annual operatin...

October 13, 2023, 9:01 am

Qualcomm's bright future just got extended, right at resistance

So look, no beating around the bush this time; when a high-quality asset (a business in this case) goes on sale because of outside forces weighing in ...

October 13, 2023, 9:00 am

Exelon corporation's calvin butler on wh ceo meeting: you have an administration willing to listen

Exelon Corporation CEO Calvin Butler joins 'Squawk Box' to discuss President Biden's meeting with CEOs ...

October 13, 2023, 8:43 am

Oil consolidation makes sense to 'continue to lower the cost of production': tortoise's rob thummel

Rob Thummel, Tortoise senior portfolio manager, joins 'Squawk Box' to discuss Exxon Mobil's acquisition...

October 13, 2023, 8:40 am

Cassava shares plummet after investigation accuses researcher of ‘egregious misconduct'

Shares of biotech company Cassava sciences Inc. were slammed in extended trading Thursday, after the pu...

October 13, 2023, 8:39 am

Volitionrx holds roundtable on sepsis management

VolitionRx (NYSE-A:VNRX) has revealed insights from a recent Key Opinion Leader (KOL) roundtable focused on sepsis management. The KOL roundtable brou...

October 13, 2023, 8:35 am

Tiziana life sciences reveals positive pet scan results with foralumab to treat ms patients

Tiziana Life sciences Ltd (NASDAQ:TLSA) announced that a reduction in activated microglia, as seen in...

October 13, 2023, 8:34 am

Amylyx pharmaceuticals shares fall after als treatment is rejected by european regulator

Amylyx Pharmaceuticals Inc. AMLX, -4.60% shares fell 7.5% premarket on Friday after the company said the European Medicines Agency had confirmed its n...

October 13, 2023, 8:31 am

Is this dividend stock a screaming buy after its latest acquisition?

Amgen finally closed its acquisition of Horizon Therapeutics despite a regulatory hiccup. Horizon has a relatively impressive portfolio although, like...

October 13, 2023, 8:30 am

Eu regulator declines to recommend amylyx' als drug

Amylyx Pharmaceuticals said on Friday the European Union medicines regulator for the second time declined to recommend a marketing authorisation for t...

October 13, 2023, 8:28 am

Manchester united board to discuss takeover proposals in coming days, ratcliffe “the frontrunner” - report

Manchester United Plc (NYSE:MANU) board is set to discuss the proposals to buy the club in a meeting du...

October 13, 2023, 8:26 am


Search within

Pages Search Results: